title: Need for improved outcome measures in pulmonary arterial hypertension related to systemic sclerosis.
authors.forename: O
authors.initials: O
authors.lastname: Distler
authors.forename: F
authors.initials: F
authors.lastname: Behrens
authors.forename: D
authors.initials: D
authors.lastname: Huscher
authors.forename: I
authors.initials: I
authors.lastname: Foeldvari
authors.forename: A
authors.initials: A
authors.lastname: Zink
authors.forename: P
authors.initials: P
authors.lastname: Nash
authors.forename: C P
authors.initials: CP
authors.lastname: Denton
authors.forename: M
authors.initials: M
authors.lastname: Humbert
authors.forename: M
authors.initials: M
authors.lastname: Matucci-Cerinic
authors.forename: J
authors.initials: J
authors.lastname: Seibold
authors.forename: L
authors.initials: L
authors.lastname: Rubin
authors.forename: D E
authors.initials: DE
authors.lastname: Furst
mesh_terms: D000959:Antihypertensive Agents / Q000627:therapeutic use; D003697:Delphi Technique; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy* / Q000209:etiology*; D012595:Scleroderma, Systemic / Q000150:complications*; D016896:Treatment Outcome
chemical_list: D000959:Antihypertensive Agents